ATC Group: C02AB01 Methyldopa (levorotatory)

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C02AB01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C02 Antihypertensives
3 C02A Antiadrenergic agents, centrally acting
4 C02AB Methyldopa
5 C02AB01 Methyldopa (levorotatory)

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 1 g
PAREN - Parenteral 1 g

Active ingredients in C02AB01

Active Ingredient Description
Alphamethyldopa

Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.

Related product monographs

Title Information Source Document Type  
DOPAMET Film-coated tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Cyprus (CY)

Ecuador (EC)

France (FR)

Germany (DE)

Hong Kong (HK)

Ireland (IE)

Japan (JP)

Mexico (MX)

South Africa (ZA)

Spain (ES)

Turkey (TR)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.